Abstract: TH-PO0291
Single-Cell Multiomic Characterization Reveals Endothelial Remodeling-Fibrosis Trajectory in Kidney Biopsy Samples of Patients with Malignant Hypertension
Session Information
- Hypertension and CVD: Mechanisms
November 06, 2025 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Hypertension and CVD
- 1601 Hypertension and CVD: Basic
Authors
- Ma, Yixin, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Xu, Lubin, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Huang, Zheng, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China
- Yin, Saifu, Department of Urology/Kidney Transplantation Center, West China Hospital, Sichuan University, Beijing, China
- Li, Yun, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China
- Zhang, Guoqing, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China
- Cao, Shilu, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Hu, Yuting, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Lin, Yitao, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Zhu, Jiahao, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Lin, Tao, Department of Urology/Kidney Transplantation Center, West China Hospital, Sichuan University, Beijing, China
- Jiang, Lan, Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing, China
- Chen, Limeng, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
Background
Renal endothelial cells (ECs) exhibit significant heterogeneity and remarkable plasticity in various physiological and pathological conditions. Malignant hypertension (mHTN), predominantly affecting young males, is characterized by thrombotic microangiopathy (TMA) in renal pathology, reflecting extensive endothelial injury. However, the precise cellular responses of renal ECs during mHTN remain poorly understood.
Methods
We collected the renal biopsy samples of nine mHTN patients, ten patients with benign hypertension (BHT), and nineteen healthy transplantation donors at the zero hour of surgery. UDA-seq (Universal Droplet Microfluidics-Based Combinatorial Indexing for Massive-Scale Multimodal Single-cell Sequencing) technology was applied for single-nucleus RNA sequencing (snRNAseq) and ATAC sequencing (snATACseq) of renal biopsy specimens.
Results
Different from the BHT patients, the mHTN patients were young males (88.9%) with an average eGFR of 31 mL/min/1.73m2. In the vascular interstitial compartment including endothelial cells, vascular smooth muscle cells/pericytes and fibroblasts, up-regulated genes in mHTN patients were enriched in pathways such as extracellular matrix organization, vascular development and angiogenesis regulation. Subclustering of peritubular capillary endothelial cells (EC-PTCs) yielded 8 clusters, where subclusters 4 and 5 were underrepresented in healthy controls (<25%). Among these disease-enriched cell clusters, subcluster 4 expressing a high fetal kidney endothelial cell signature was defined as “remodeling” EC-PTCs and subcluster 5 expressing profibrotic marker ACKR1 and VCAM1 was defined as “fibrotic”. Pseudotime trajectory analysis from normal to profibrotic cell subclusters identified key transcriptional factors including an endothelial lineage determining factor ETV2, endothelial-to-mesenchymal transition-related factor SOX9 and oxidative stress-responsive factor BACH1.
Conclusion
We are the first to report the single ECs-based pathophysiology process, injury trajectory from remodeling to fibrosis, with prioritized transcriptional factors in mHTN patients, which sheds light on the future precision medication.
Funding
- Government Support – Non-U.S.